Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 617 articles:
HTML format
Text format



Single Articles


    April 2017
  1. WINSTON A, Julie F, Fidler S
    HIV cure strategies: response to ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:1051-1052.
    PubMed     Text format    


  2. LE GARFF G, Samri A, Lambert-Niclot S, Even S, et al
    Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
    AIDS. 2017;31:1048-1051.
    PubMed     Text format    


  3. MCLEAN FE, Gathogo E, Goodall D, Jones R, et al
    Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
    AIDS. 2017;31:1047-1048.
    PubMed     Text format    


  4. FRANCESCHI S, Clifford GM
    Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status.
    AIDS. 2017;31:1045-1046.
    PubMed     Text format    


  5. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
    AIDS. 2017;31:1025-1034.
    PubMed     Text format     Abstract available


  6. BREGIGEON S, Galinier A, Zaegel-Faucher O, Cano CE, et al
    Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001507.
    PubMed     Text format     Abstract available


  7. SCHAEFER R, Gregson S, Eaton JW, Mugurungi O, et al
    Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from a general-population cohort in Zimbabwe.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001506.
    PubMed     Text format     Abstract available


  8. GIBELLINI L, Pecorini S, de Biasi S, Bianchini E, et al
    HIV-DNA content in different CD4+ T cell subsets correlates with CD4: CD8 ratio or length of efficient treatment.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001510.
    PubMed     Text format     Abstract available


  9. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511.
    PubMed     Text format     Abstract available


  10. MAURICE JB, Patel A, Scott AJ, Patel K, et al
    Prevalence and risk factors of non-alcoholic fatty liver disease in HIV-monoinfection: a systematic review and meta-analysis.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001504.
    PubMed     Text format     Abstract available


  11. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    PubMed     Text format     Abstract available


  12. PUTCHAROEN O, Wattanachanya L, Sophonphan J, Siwamogsatham S, et al
    New-onset diabetes in hiv treated adults from thailand: predictors, long-term renal and cardiovascular outcomes.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001496.
    PubMed     Text format     Abstract available


  13. SWEENEY P, Gray SC, Purcell DW, Sewell J, et al
    Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001501.
    PubMed     Text format     Abstract available


  14. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001503.
    PubMed     Text format     Abstract available


  15. MCGRATH N, Grapsa E
    Does ART change partnership dynamics and HIV risk behaviours among PLWH? A cohort study in KwaZulu-Natal, South Africa.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001502.
    PubMed     Text format     Abstract available


  16. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving towards test and start: learning from the experience of universal ART programs for HIV-infected pregnant/breastfeeding women.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001498.
    PubMed     Text format     Abstract available


  17. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    PubMed     Text format     Abstract available


  18. VAN BILSEN WP, van den Berg CH, Rijnders BJ, Brinkman K, et al
    Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in hiv-infected patients: a multicenter cohort study.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001492.
    PubMed     Text format     Abstract available


  19. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS).
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001493.
    PubMed     Text format     Abstract available


  20. MAHY M, Penazzato M, Ciaranello A, Mofenson L, et al
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS. 2017;31 Suppl 1:S13-S22.
    PubMed     Text format     Abstract available


  21. WILSON KC, Mhangara M, Dzangare J, Eaton JW, et al
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS. 2017;31 Suppl 1:S95-S102.
    PubMed     Text format     Abstract available


  22. SHENG B, Marsh K, Slavkovic AB, Gregson S, et al
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS. 2017;31 Suppl 1:S87-S94.
    PubMed     Text format     Abstract available


  23. MASQUELIER B, Eaton JW, Gerland P, Pelletier F, et al
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS. 2017;31 Suppl 1:S77-S85.
    PubMed     Text format     Abstract available


  24. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS. 2017;31 Suppl 1:S69-S76.
    PubMed     Text format     Abstract available


  25. EATON JW, Bao L
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS. 2017;31 Suppl 1:S61-S68.
    PubMed     Text format     Abstract available


  26. NIU X, Zhang A, Brown T, Puckett R, et al
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS. 2017;31 Suppl 1:S51-S59.
    PubMed     Text format     Abstract available


  27. SILHOL R, Gregson S, Nyamukapa C, Mhangara M, et al
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS. 2017;31 Suppl 1:S41-S50.
    PubMed     Text format     Abstract available


  28. ANDEREGG N, Johnson LF, Zaniewski E, Althoff KN, et al
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS. 2017;31 Suppl 1:S31-S40.
    PubMed     Text format     Abstract available


  29. MAHIANE SG, Marsh K, Grantham K, Crichlow S, et al
    Improvements in Spectrum's fit to program data tool.
    AIDS. 2017;31 Suppl 1:S23-S30.
    PubMed     Text format     Abstract available


  30. STOVER J, Brown T, Puckett R, Peerapatanapokin W, et al
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS. 2017;31 Suppl 1:S5-S11.
    PubMed     Text format     Abstract available


  31. CASE KK, Gregson S, Mahy M, Ghys PD, et al
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS. 2017;31 Suppl 1:S1-S4.
    PubMed     Text format    


    March 2017
  32. MONTES ML, Olveira A, Ahumada A, Aldamiz T, et al
    Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001465.
    PubMed     Text format     Abstract available


  33. VALVERDE-VILLEGAS JM, Medeiros RM, Andrade KP, Jacovas VC, et al
    Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001491.
    PubMed     Text format     Abstract available


  34. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001487.
    PubMed     Text format     Abstract available


  35. EKINS S, Mathews P, Saito EK, Diaz N, et al
    alpha-7-nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001488.
    PubMed     Text format     Abstract available


  36. BELLAVIA A, Williams PL, Dimeglio LA, Hazra R, et al
    Delay in sexual maturation in perinatally HIV-infected youth is mediated by poor growth.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001486.
    PubMed     Text format     Abstract available


  37. DE MENDOZA C, Cabezas T, Caballero E, Requena S, et al
    HIV-2 Epidemic in Spain - Challenges and Missing Opportunities.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001485.
    PubMed     Text format     Abstract available


  38. EL-DIWANY R, Breitwieser FP, Soliman M, Skaist AM, et al
    Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001480.
    PubMed     Text format     Abstract available


  39. YU C, Seaton M, Letendre S, Heaton R, et al
    Plasma Dickkopf-related Protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001481.
    PubMed     Text format     Abstract available


  40. RAJASURIAR R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, et al
    Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001475.
    PubMed     Text format     Abstract available


  41. STEKLER JD, Ure G, Dragavon J, Chang M, et al
    Detection of HIV RNA in dried blood spots and oral fluids.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001477.
    PubMed     Text format     Abstract available


  42. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in TB/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001471.
    PubMed     Text format    


  43. IANTORNO M, Schar M, Soleimanifard S, Brown TT, et al
    Coronary artery endothelial dysfunction is present in HIV positive individuals without significant coronary artery disease.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001469.
    PubMed     Text format     Abstract available


  44. MARSHALL BD, Tate JP, Mcginnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001473.
    PubMed     Text format     Abstract available


  45. HASSAN AS, Pybus OG, Sanders EJ, Albert J, et al
    Defining HIV-1 transmission clusters based on sequence data: a systematic review and perspectives.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001470.
    PubMed     Text format     Abstract available


  46. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001464.
    PubMed     Text format     Abstract available


  47. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision (VMMC) uptake among adult men in Tanzania: A randomised controlled trial.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001440.
    PubMed     Text format     Abstract available


  48. MAHALINGASIVAM V, Gathogo E, Bramham K, Post FA, et al
    Successful pregnancy in an HIV-positive kidney transplant recipient.
    AIDS. 2017;31:872-873.
    PubMed     Text format    


  49. JINDAL AK, Ahluwalia J, Sharma A, Dhawan S, et al
    HIV-infected children with hepatomegaly and ascites: is there something more than an infection?
    AIDS. 2017;31:870-872.
    PubMed     Text format    


  50. GOEDERT JJ
    The microbiota and HIV: shedding light on dark matters.
    AIDS. 2017;31:863-865.
    PubMed     Text format    



  51. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    AIDS. 2017;31:835-846.
    PubMed     Text format     Abstract available


  52. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.
    AIDS. 2017;31:827-833.
    PubMed     Text format     Abstract available


  53. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
    AIDS. 2017;31:771-779.
    PubMed     Text format     Abstract available


  54. OZANNE A, Duffau P, Dauchy FA, Rigothier C, et al
    Activation, senescence and inflammation markers in HIV patients: association with renal function.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001461.
    PubMed     Text format     Abstract available


  55. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001448.
    PubMed     Text format     Abstract available


  56. PRICE H, Dunn D, Zachary T, Vudriko T, et al
    Hepatitis B serological markers and plasma DNA concentrations: baseline results from the DART trial.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001454.
    PubMed     Text format     Abstract available


  57. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001455.
    PubMed     Text format     Abstract available


  58. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Text format     Abstract available


  59. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Text format     Abstract available


  60. SAMUELS R, Bayerri CR, Sayer JA, Price DA, et al
    TDF associated renal tubular dysfunction: non-invasive assessment of mitochondrial injury.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001466.
    PubMed     Text format     Abstract available


  61. MOORE CB, Capparelli EV, Samson P, Bwakura-Dangarembizi M, et al
    CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001463.
    PubMed     Text format     Abstract available


  62. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    "It's inside my body and it's mine".
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452.
    PubMed     Text format     Abstract available


  63. MUKANDAVIRE C, Low A, Mburu G, Trickey A, et al
    Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001458.
    PubMed     Text format     Abstract available


  64. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001451.
    PubMed     Text format     Abstract available


  65. GAGNEUX-BRUNON A, Rochereau N, Botelho-Nevers E, Lucht F, et al
    Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001460.
    PubMed     Text format     Abstract available


  66. MCALLISTER J, Towns JM, Mcnulty A, Pierce AB, et al
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447.
    PubMed     Text format     Abstract available


  67. MANGAL TD
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437.
    PubMed     Text format     Abstract available


  68. MOTA TM, Rasmussen TA, Rhodes A, Tennakoon S, et al
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001442.
    PubMed     Text format     Abstract available


  69. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    PubMed     Text format     Abstract available


  70. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    PubMed     Text format     Abstract available


  71. KONG X, Kigozi G, Ssekasanvu J, Nalugoda F, et al
    Medical male circumcision coverage in Rakai, Uganda.
    AIDS. 2017;31:735-737.
    PubMed     Text format     Abstract available


  72. CZAICKI NL, Holmes CB, Sikazwe I, Bolton C, et al
    Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics.
    AIDS. 2017;31:689-696.
    PubMed     Text format     Abstract available


  73. HARAWA NT, Holloway IW, Leibowitz A, Weiss R, et al
    Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition.
    AIDS. 2017;31:739-740.
    PubMed     Text format    


  74. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretroviral medication.
    AIDS. 2017;31:719-726.
    PubMed     Text format     Abstract available


  75. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    AIDS. 2017;31:613-622.
    PubMed     Text format     Abstract available


  76. TOBIN SC
    Evaluating the generalizability of clinical trials of direct-acting antivirals for HIV/HCV-coinfection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001439.
    PubMed     Text format    


  77. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Text format     Abstract available


  78. MARCUS JL, Leyden WA, Chao CR, Horberg MA, et al
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001434.
    PubMed     Text format     Abstract available


  79. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    PubMed     Text format     Abstract available


  80. KIRKEGAARD-KLITBO DM, Mejer N, Knudsen TB, Moller HJ, et al
    Soluble CD163 Predicts Incident Chronic Lung, Kidney and Liver Disease in HIV Infection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001432.
    PubMed     Text format     Abstract available


  81. MAHEU-GIROUX M, Tanser F, Boily MC, Pillay D, et al
    Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001435.
    PubMed     Text format     Abstract available


    February 2017
  82. BENGTSON AM, Pence BW, Moore R, Mimiaga MJ, et al
    The relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001431.
    PubMed     Text format     Abstract available


  83. BRYANT AK, Moore DJ, Burdo TH, Lakritz JR, et al
    Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001425.
    PubMed     Text format     Abstract available


  84. VESA J, Chaillon A, Wagner GA, Anderson CM, et al
    Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001445.
    PubMed     Text format     Abstract available



  85. First evidence of intra-familial transmission of an HIV-1 M/O intergroup recombinant virus: Erratum.
    AIDS. 2017;31:601.
    PubMed     Text format    


  86. KASIRYE RP, Grosskurth H, Munderi P, Levin J, et al
    Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.
    AIDS. 2017;31:577-582.
    PubMed     Text format     Abstract available


  87. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    PubMed     Text format     Abstract available


  88. TAKUVA S, Brown AE, Pillay Y, Delpech V, et al
    The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.
    AIDS. 2017;31:545-552.
    PubMed     Text format     Abstract available


  89. JOSE S, Nelson M, Phillips A, Chadwick D, et al
    Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.
    AIDS. 2017;31:485-492.
    PubMed     Text format     Abstract available


  90. MANDAL S, Prathipati PK, Kang G, Zhou Y, et al
    Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
    AIDS. 2017;31:469-476.
    PubMed     Text format     Abstract available


  91. RAFIEI N, Woolley I, Korman TM, Chibo D, et al
    Integrase-resistant HIV in an antiretroviral-naive patient in Australia.
    AIDS. 2017;31:598-600.
    PubMed     Text format    


  92. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
    AIDS. 2017;31:596-598.
    PubMed     Text format    


  93. WEN Y, Li JZ
    Post-treatment HIV controllers or spontaneous controllers in disguise?
    AIDS. 2017;31:587-589.
    PubMed     Text format    


    January 2017
  94. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy.
    AIDS. 2017;31:451-453.
    PubMed     Text format     Abstract available


  95. SCHUSTER C, Binder C, Strassl R, Aichelburg MC, et al
    Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.
    AIDS. 2017;31:395-400.
    PubMed     Text format     Abstract available


  96. REID M, Ma Y, Scherzer R, Price JC, et al
    Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
    AIDS. 2017;31:385-393.
    PubMed     Text format     Abstract available



  97. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


  98. AKUA T, Rahav G, Saragani Y, Hizi A, et al
    Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase.
    AIDS. 2017;31:343-353.
    PubMed     Text format     Abstract available


  99. BORGHETTI A, Baldin G, Capetti A, Sterrantino G, et al
    Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
    AIDS. 2017;31:457-459.
    PubMed     Text format    


  100. AHMAD A, Rinaldo CR
    A novel anti-HIV immunotherapy to cure HIV.
    AIDS. 2017;31:447-449.
    PubMed     Text format    


  101. SORIANO V, Sherman KE, Barreiro P
    Hepatitis Delta and HIV Infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001424.
    PubMed     Text format     Abstract available


  102. SU S, Wang Q, Xu W, Yu F, et al
    A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001415.
    PubMed     Text format     Abstract available


  103. PATEL EU, Gianella S, Newell K, Tobian AA, et al
    Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001412.
    PubMed     Text format     Abstract available


  104. PINATO DJ, Pria AD, Sharma R, Bower M, et al
    Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001422.
    PubMed     Text format     Abstract available


  105. LIFSON AR, Grund B, Gardner EM, Kaplan R, et al
    Improved quality of life with immediate initiation of antiretroviral therapy in the strategic timing of antiretroviral therapy trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001417.
    PubMed     Text format     Abstract available


  106. CHEHOUD C, Stieh DJ, Bailey AG, Laughlin AL, et al
    Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001421.
    PubMed     Text format     Abstract available


  107. SU T, Mutsaerts HJ, Caan MW, Wit FW, et al
    Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001414.
    PubMed     Text format     Abstract available


  108. CROOME N, Ahluwalia M, Hughes LD, Abas M, et al
    Patient-reported barriers and facilitators to antiretroviral adherence in Sub-Saharan Africa: a systematic review.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001416.
    PubMed     Text format     Abstract available


  109. JOSHI PH, Miller PE, Martin SS, Jones SR, et al
    Greater remnant lipoprotein cholesterol reduction with pitavastatin compared to pravastatin in HIV-infected patients: The INTREPID trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001423.
    PubMed     Text format     Abstract available


  110. NOWAK RG, Bentzen SM, Ravel J, Crowell TA, et al
    Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected men who have sex with men (MSM) in Nigeria.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001409.
    PubMed     Text format     Abstract available


  111. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408.
    PubMed     Text format     Abstract available



  112. Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013).
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001411.
    PubMed     Text format     Abstract available


  113. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001400.
    PubMed     Text format     Abstract available


  114. MCCOY SI, Njau PF, Fahey C, Kapologwe N, et al
    Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania: a randomized trial.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001406.
    PubMed     Text format     Abstract available


  115. KRAFT JC, McConnachie LA, Koehn J, Kinman L, et al
    Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001405.
    PubMed     Text format     Abstract available


  116. MONTOYA JL, Iudicello J, Oppenheim HA, Fazeli PL, et al
    Coagulation imbalance and neurocognitive functioning in older HIV+ adults on suppressive antiretroviral therapy.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001404.
    PubMed     Text format     Abstract available


  117. BALINANG JM, Masvekar RR, Hauser KF, Knapp PE, et al
    Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001398.
    PubMed     Text format     Abstract available


  118. SEREMBA E, Ssempijja V, Kalibbala S, Gray RH, et al
    Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001399.
    PubMed     Text format     Abstract available


  119. BAI F, Iannuzzi F, Merlini E, Borghi L, et al
    Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naive HIV-infected patients.
    AIDS. 2017;31:311-314.
    PubMed     Text format     Abstract available


  120. HOST KM, Horner MJ, van der Gronde T, Moses A, et al
    Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:318-319.
    PubMed     Text format    


  121. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al.
    AIDS. 2017;31:317.
    PubMed     Text format    


  122. POWIS KM, Slogrove AL, Mofenson L
    Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.
    AIDS. 2017;31:315-316.
    PubMed     Text format    


  123. CACERES CF
    Educational attainment and intersectionality in the response to HIV antiretroviral treatment in Europe.
    AIDS. 2017;31:305-307.
    PubMed     Text format    


  124. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV.
    AIDS. 2017;31:295-304.
    PubMed     Text format     Abstract available


  125. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    PubMed     Text format     Abstract available


  126. CALZA L, Magistrelli E, Colangeli V, Borderi M, et al
    Significant association between statin-associated myalgia and vitamin d deficiency among treated hiv-infected patients.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001397.
    PubMed     Text format     Abstract available


  127. NUNN AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, et al
    Defining the HIV Pre-Exposure Prophylaxis Care Continuum.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001385.
    PubMed     Text format    


  128. SABIN CA, Howarth A, Jose S, Hill T, et al
    Association between engagement in-care and mortality in HIV-positive persons: a cohort study.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001373.
    PubMed     Text format     Abstract available


  129. WEINBERG A, Mussi-Pinhata MM, Yu Q, Cohen RA, et al
    Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001393.
    PubMed     Text format     Abstract available


  130. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments NK-mediated antibody-dependent cellular cytotoxicity (ADCC) of HIV-1 infected autologous CD4+ T cells regardless of MHC-I downregulation.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001380.
    PubMed     Text format     Abstract available


  131. FERREIRA MP, Coghill AE, Chaves CB, Bergmann A, et al
    Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013).
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001367.
    PubMed     Text format     Abstract available


  132. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretrovirals: early evidence from a randomized controlled trial in Uganda.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001387.
    PubMed     Text format     Abstract available


  133. MARTIN GE, Gossez M, Williams JP, Stohr W, et al
    Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001382.
    PubMed     Text format     Abstract available


  134. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    PubMed     Text format     Abstract available


  135. TINAGO W, Cotter AG, Sabin C, Macken A, et al
    Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative subjects.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001372.
    PubMed     Text format     Abstract available


  136. ANGIN M, Fathi A, King M, Ledoux MB, et al
    Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001390.
    PubMed     Text format     Abstract available


  137. STREECK H, Verheyen J, Storim J, Dittmer U, et al
    Pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:176-177.
    PubMed     Text format    


  138. SPECTOR SA, Rappaport J
    HIV cure strategists: ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:167-168.
    PubMed     Text format    



  139. Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.
    AIDS. 2017;31:127-135.
    PubMed     Text format     Abstract available


  140. NEWSUM AM, Ho CK, Lieveld FI, van de Laar TJ, et al
    The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2017;31:105-112.
    PubMed     Text format     Abstract available


  141. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    AIDS. 2017;31:97-104.
    PubMed     Text format     Abstract available


  142. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques.
    AIDS. 2017;31:5-14.
    PubMed     Text format     Abstract available


  143. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2017;31:147-157.
    PubMed     Text format     Abstract available


    December 2016
  144. VENKATACHARI NJ, Jain S, Walker L, Bivalkar-Mehla S, et al
    Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001379.
    PubMed     Text format     Abstract available


  145. PETERS L, Cozzi-Lepri A
    Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001378.
    PubMed     Text format     Abstract available


  146. BRENNER BG, Ibanescu RI, Hardy I, Stephens D, et al
    Large cluster outbreaks sustain the HIV epidemic among men having sex with men (MSM) in Quebec from 2002 to 2015.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001383.
    PubMed     Text format     Abstract available


  147. HARPER KN
    New mouse models provide insights into how to design a more effective HIV vaccine.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001371.
    PubMed     Text format    


  148. HARPER KN
    Do HIV-infected children who do not develop AIDS hold clues to a cure?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001370.
    PubMed     Text format    


  149. HARPER KN
    To break patent or not to break patent: What is in the best interests of HIV patients in low-income countries?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001369.
    PubMed     Text format    


  150. DILLON SM, Kibbie J, Lee EJ, Guo K, et al
    Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001366.
    PubMed     Text format     Abstract available


  151. KROIDL A, Ello F, Mgaya J, Lennemann T, et al
    Virological efficacy of 24-weeks fozivudine based regimen in ART-naive patients from tanzania and cote d'Ivoire.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  152. MORRIS A, Fitzpatrick M, Bertolet M, Qin S, et al
    Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease: A randomized pilot study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  153. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  154. DIRAJLAL-FARGO S, Alam SM, Sattar A, Kulkarni M, et al
    Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  155. LUNSKY Y, Durbin A, Brown HK, Bansal S, et al
    Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  156. MERCHANTE N, Rivero-Juarez A, Tellez F, Merino D, et al
    Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  157. NELSON KN, Hui Q, Rimland D, Xu K, et al
    Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naive U.S. veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2016
  158. WESTREICH D, Cates J, Cohen M, Weber KM, et al
    Smoking, HIV, and risk of pregnancy loss.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  159. PAZ-BAILEY G, Wejnert C, Mendoza MC, Prejean J, et al
    Response to diversification of risk-reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2900-2901.
    PubMed     Text format    


  160. KIPPAX S, Holt M
    Diversification of risk reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2898-2899.
    PubMed     Text format    


  161. AUTRAN B, Pogliaghi M, Katlama C
    Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2896-2898.
    PubMed     Text format    


  162. PALMER CS, Crowe SM
    Immunometabolism may provide new insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2895-2896.
    PubMed     Text format    


  163. DARCIS G, Coombs RW, Van Lint C
    Exploring the anatomical HIV reservoirs: role of the testicular tissue.
    AIDS. 2016;30:2891-2893.
    PubMed     Text format    


  164. VASYLYEVA TI, Friedman SR, Lourenco J, Gupta S, et al
    Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    AIDS. 2016;30:2885-2890.
    PubMed     Text format     Abstract available


  165. DE BOER MG, van den Berk GE, van Holten N, Oryszcyn JE, et al
    Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.
    AIDS. 2016;30:2831-2834.
    PubMed     Text format     Abstract available


  166. TORT O, Sanchez-Palomino S, Escriba T, Calvo C, et al
    omega-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?
    AIDS. 2016;30:2733-2735.
    PubMed     Text format    


  167. BRENNER B, Wainberg MA
    We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    AIDS. 2016;30:2725-2727.
    PubMed     Text format    


  168. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


  169. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
    AIDS. 2016;30:2685-2695.
    PubMed     Text format     Abstract available


  170. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    AIDS. 2016;30:2659-2663.
    PubMed     Text format     Abstract available


  171. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
    AIDS. 2016;30:2599-2610.
    PubMed     Text format     Abstract available


  172. VANCE DE
    Interpreting the influence of race and cognitive activity on neurocognition in adults aging with HIV.
    AIDS. 2016.
    PubMed     Text format    


  173. YOUNAS M, Carrat F, Finge S, Desaint C, et al
    Immune activation, smoking, and vaccine response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  174. VIGANO S, Negron JJ, Tse S, Chowdhury FZ, et al
    HLA-G+ HIV-1-specific CD8 T cells are associated with HIV-1 immune control.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  175. BUTTERFIELD TR, Hanna DB, Kaplan RC, Kizer JR, et al
    Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  176. GOSSELIN A, Wiche Salinas TR, Planas D, Wacleche VS, et al
    HIV persists in CCR6+CD4+ T-cells from colon and blood during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  177. KRUEGER KR, Adeyemi O, Leurgans S, Shah RC, et al
    Association of cognitive activity and neurocognitive function in blacks and whites with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  178. SELVA KJ, Kent SJ, Parsons MS
    Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  179. SUDFELD CR, Kaaya S, Gunaratna NS, Mugusi F, et al
    Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  180. SHIAU S, Strehlau R, Technau KG, Patel F, et al
    Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  181. GUELER A, Moser A, Calmy A, Gunthard HF, et al
    Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  182. MOFENSON LM, Baggaley RC, Mameletzis I
    Tenofovir Disoproxil Fumarate Safety for Women and their Infants during Pregnancy and Breastfeeding: Systematic Review.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  183. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  184. GREEN N, Hoenigl M, Chaillon A, Anderson CM, et al
    Partner services in adults with acute and early HIV infection, San Diego, 1996-2014.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  185. KARDASHIAN A, Ma Y, Scherzer R, Price JC, et al
    Sex differences in the association of HIV infection with hepatic steatosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  186. BRAND D, Capsec J, Chaillon A, Cazein F, et al
    HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  187. NAKAGAWA F, Phillips A
    An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings: an application in the UK.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  188. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV: trends and disparities from 1996 to 2013.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  189. CHRISTOPOULOS K, Hartogensis W, Glidden DV, Pilcher CD, et al
    The lorenz curve: a novel method for understanding viral load distribution at the population level.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  190. PELUSO MJ, Valcour V, Phanuphak N, Ananworanich J, et al
    Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    October 2016
  191. MIRKOVIC KR, Rivadeneira ED, Broyles LN
    Children and alternative service delivery models: a case for inclusion.
    AIDS. 2016;30:2569-2570.
    PubMed     Text format    


  192. UNAL G, Mourez T, Leoz M, Alessandri-Gradt E, et al
    First report of transmission of a highly resistant strain of HIV-1 group O.
    AIDS. 2016;30:2565-2568.
    PubMed     Text format    


  193. ZOLLA-PAZNER S
    Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.
    AIDS. 2016;30:2551-2553.
    PubMed     Text format    


  194. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    AIDS. 2016;30:2495-2504.
    PubMed     Text format     Abstract available


  195. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2016;30:2469-2476.
    PubMed     Text format     Abstract available


  196. FRIEDMAN EE, Duffus WA
    Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016;30:2529-2536.
    PubMed     Text format     Abstract available


  197. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before ART availability: Fertility by duration of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  198. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  199. SPRENGER HG, Bierman WF, Martes MI, Graaff R, et al
    Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  200. HARPER KN
    New research on using CRISPR/Cas9 to treat HIV.
    AIDS. 2016.
    PubMed     Text format    


  201. GIANELLA S, Taylor J, Brown TR, Kaytes A, et al
    Can research at the end-of-life be a useful tool to advance HIV cure?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  202. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  203. CHOPERA DR, Ntale R, Ndabambi N, Garrett N, et al
    Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  204. MERCHANTE N, Ibarra S, Revollo B, Rodriguez-Arrondo F, et al
    Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients (RIS-HEP12/GEHEP-002 study).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  205. TAKEMOTO JK, Miller TL, Wang J, Jacobson DL, et al
    Insulin Resistance in HIV-Infected Youth is associated with decreased mitochondrial respiration.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  206. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  207. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  208. DARCIS G, Bouchat S, Kula A, Van Driessche B, et al
    Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  209. AHRENSTORF G, Low HZ, Kniesch K, Ordonez D, et al
    LILRA3 deletion is a genetic risk factor of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  210. HARPER KN
    The 2nd Durban Declaration draws attention to progress in the fight against HIV and work yet to do.
    AIDS. 2016.
    PubMed     Text format    


  211. HARPER KN
    HIV-altered gut microbiome may be driving disease progression.
    AIDS. 2016.
    PubMed     Text format    


  212. DILLON SM, Frank DN, Wilson CC
    The gut microbiome and HIV-1 pathogenesis: a two way street.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  213. DOBRA A, Barnighausen T, Vandormael A, Tanser F, et al
    Space-time migration patterns and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    September 2016
  214. GUPTA SK, Kamendulis LM, Clauss MA, Liu Z, et al
    A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
    AIDS. 2016;30:2389-91.
    PubMed     Text format    


  215. LUZURIAGA K, Persaud D
    Treatment interruption after early-treated perinatal HIV-1 infection.
    AIDS. 2016;30:2381-3.
    PubMed     Text format    


  216. BREW BJ
    Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
    AIDS. 2016;30:2379-80.
    PubMed     Text format    


  217. DE BOER M, van den Berk G, van Holten N, Oryszczyn J, et al
    Intolerance of dolutegravir containing cART regimens in real life clinical practice.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  218. TAO J, Qian HZ, Kipp AM, Ruan Y, et al
    Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed hiv-infected chinese men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  219. BEDOYA LM, Beltran M, Obregon-Calderon P, Garcia-Perez J, et al
    Hydroxytyrosol. a new class of microbicide displaying broad anti HIV-1 activity.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  220. SCHERZER R, Heymsfield SB, Rimland D, Powderly WG, et al
    Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  221. SOEPNEL LM, Norris SA, Schrier VJ, Browne JL, et al
    The association between HIV, antiretroviral therapy and gestational diabetes mellitus: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  222. THORNE C, Turkova A, Indolfi G, Venturini E, et al
    Co-infection with HIV and HCV in 229 children and young adults living in Europe.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  223. MURI L, Gamell A, Ntamatungiro AJ, Glass TR, et al
    Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  224. JENABIAN MA, Costiniuk CT, Mehraj V, Ghazawi FM, et al
    Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  225. MUKHERJEE PK, Chen H, Patton LL, Evans S, et al
    Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 Infected participants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  226. GUARDO AC, Joe PT, Miralles L, Bargallo ME, et al
    Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  227. TELWATTE S, Brumme CJ, Hearps AC, Latham CF, et al
    Increasing Prevalence of Synonymous Mutations K65K and K66K in HIV-1 subtype B reverse transcriptase.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  228. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  229. DEL AMO J
    Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe (1996-2013): a collaborative cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  230. PRENDERGAST AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, et al
    Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  231. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of SIV reservoirs in the brain of virally suppressed macaques.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  232. ALAEI K, Paynter CA, Juan SC, Alaei A, et al
    Using PrEP, losing condoms? PrEP promotion may undermine safe sex.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  233. NEWSUM AM, Ho CK, Lieveld FI, Van De Laar TJ, et al
    The hepatitis C virus NS3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  234. LEVIN MJ, Lindsey JC, Kaplan SS, Schimana W, et al
    Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  235. PINES HA, Wertheim JO, Liu L, Garfein RS, et al
    Concurrency and HIV transmission network characteristics among men who have sex with men with recent HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  236. GAY CL, Willis SJ, Cope AB, Kuruc JD, et al
    Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  237. HLEYHEL M, Goujon S, Sibiude J, Blanche S, et al
    In utero exposure to NELFINAVIR-EMS.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  238. KUZNIK A, Iliyasu G, Habib AG, Musa BM, et al
    Initiation of antiretroviral therapy based on the 2015 WHO guidelines: A cost-effectiveness analysis in Nigeria, South Africa, Uganda and India.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  239. RYLANCE J, Mchugh G, Metcalfe J, Mujuru H, et al
    Chronic lung disease in HIV-infected children established on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  240. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term body composition changes in antiretroviral-treated HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  241. SCHNEIDER JA, Kozloski M, Michaels S, Skaathun B, et al
    Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  242. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption: Erratum.
    AIDS. 2016;30:2259.
    PubMed     Text format    


  243. VASSALLO M, De Monte A, Durant J, Dunais B, et al
    Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
    AIDS. 2016;30:2257-8.
    PubMed     Text format    


  244. CAMASMIE HR, Leda SB, Lupi O, Lima RB, et al
    Chronic herpetic whitlow as the first manifestation of HIV infection.
    AIDS. 2016;30:2254-6.
    PubMed     Text format    


  245. CUERVO G, Simonetti AF, Alegre O, Sanchez-Salado JC, et al
    Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter.
    AIDS. 2016;30:2253-4.
    PubMed     Text format    


  246. RAJA SK, Aggarwal S, Raman KR, Minteer WB, et al
    From businesswoman to banana vendor: mental health implications of HIV stigma in Tanzania.
    AIDS. 2016.
    PubMed     Text format    


  247. SCHRACK JA, Jacobson LP, Althoff KN, Erlandson KM, et al
    Effect of HIV-infection and cumulative viral load on age-related decline in grip strength.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  248. ASBJORNSDOTTIR KH, Hughes JP, Wamalwa D, Langat A, et al
    Differences in virologic and immunologic response to antiretroviral therapy among HIV-1 infected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  249. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  250. TJIAM MC, Sariputra L, Armitage JD, Taylor JP, et al
    Control of early HIV-1 infection associates with plasmacytoid DC-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  251. BROWN LB, Havlir DV, Ayieko J, Mwangwa F, et al
    High levels of retention in care with streamlined care and universal test-and-treat in East Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  252. VUILLE-LESSARD E, Lebouche B, Lennox L, Routy JP, et al
    nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV mono-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  253. KELESIDIS T, Jackson N, McComsey GA, Wang X, et al
    Oxidized lipoproteins are associated with markers of inflammation andimmune activation in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  254. VILLABONA-ARENAS CJ, Vidal N, Guichet E, Serrano L, et al
    In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  255. GUPTA SK, Dube MP, Stein JH, Clauss MA, et al
    A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2016;30:2139-42.
    PubMed     Text format    


  256. MILLARD JD, Henry J, Rizvi SS, Nelson M, et al
    Direct-acting antivirals for acute hepatitis C in HIV-infected MSM.
    AIDS. 2016;30:2137-9.
    PubMed     Text format    


  257. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
    AIDS. 2016;30:2135-7.
    PubMed     Text format    


  258. BRADLEY H, Mattson CL, Beer L, Huang P, et al
    Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.
    AIDS. 2016;30:2117-24.
    PubMed     Text format     Abstract available


  259. MULANOVICH VE, Desai PA, Popat UR
    Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies: report of 5 cases after 2010.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  260. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  261. WAGNER GA, Chaillon A, Liu S, Franklin DR Jr, et al
    HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  262. SMITH JA, Daniel R
    Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  263. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  264. MOSEHOLM E, Helleberg M, Nordly SB, Rosenfeldt V, et al
    Hospital admission among HIV-exposed uninfected children compared to HIV-unexposed children - a nationwide cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  265. TCHOUNGA BK, Hnge BL, Eholie SP, Coffie PA, et al
    Effect of sex and age on outcomes among hiv-2 infected patients starting antiretroviral therapy in west africa: a multicentre cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  266. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


  267. BUGGERT M, Frederiksen J, Lund O, Betts MR, et al
    CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  268. EMMER KL, Wieczorek L, Tuyishime S, Molnar S, et al
    Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  269. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and art use in the kenya AIDS indicator survey 2012: relevance to targets for HIV diagnosis and treatment in kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  270. POLIS CB, Phillips SJ, Hillier SL, Achilles SL, et al
    Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?
    AIDS. 2016.
    PubMed     Text format    


  271. POLIS CB, Curtis KM, Hannaford PC, Phillips SJ, et al
    Update on hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, 2016.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  272. GILL AL, Green SA, Abdullah S, Le Saout C, et al
    PD1/PD-L1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-PD-L1 (Avelumab).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  273. ESCUDERO DJ, Lurie MN, Mayer KH, Weinreb C, et al
    Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  274. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  275. THOMAS GP, Li X, Post WS, Jacobson LP, et al
    Associations between antiretroviral use and subclinical coronary atherosclerosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  276. GOWDA C, Brown TT, Compher C, Forde KA, et al
    Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  277. KRUBINER CB, Faden RR, Cadigan RJ, Gilbert SZ, et al
    Advancing HIV research with pregnant women: navigating challenges and opportunities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    July 2016

  278. Long-term impact of HIV wasting on physical function: Erratum.
    AIDS. 2016;30:2007.
    PubMed     Text format    



  279. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection: Erratum.
    AIDS. 2016;30:2005.
    PubMed     Text format    


  280. CACHAY E, Soriano V
    Is HIV still a special population for the treatment of hepatitis C?
    AIDS. 2016;30:2001-3.
    PubMed     Text format    


  281. SCHALKWIJK S, Feiterna-Sperling C, Weizsacker K, Colbers A, et al
    Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant woman.
    AIDS. 2016;30:1999-2001.
    PubMed     Text format    


  282. CHIODI F
    Pneumococcal vaccination of HIV-infected young adults is an important global priority.
    AIDS. 2016;30:1991-3.
    PubMed     Text format    


  283. FRIEDMAN EE, Duffus WA
    Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  284. MATEY EJ, Tokoro M, Mizuno T, Matsumura T, et al
    Positive correlation of HIV infection with Giardia intestinalis assemblage B but not with assemblage A in asymptomatic Kenyan children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  285. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  286. BRENNAN AT, Bonawitz R, Gill CJ, Thea D, et al
    A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared to HIV-unexposed uninfected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  287. SHAHMANESH M, Schultze A, Burns F, Kirk O, et al
    The cardiovascular risk management for people living with HIV in Europe: how well are we doing?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  288. STOHR W, Dunn DT, Arenas-Pinto A, Orkin C, et al
    Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy in the PIVOT trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  289. KASSANJEE R, Pilcher CD, Busch MP, Murphy G, et al
    Viral load criteria and threshold optimization to improve HIV incidence assay characteristics - a CEPHIA analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  290. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls: Erratum.
    AIDS. 2016;30:1863.
    PubMed     Text format    



  291. Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use: Erratum.
    AIDS. 2016;30:1861.
    PubMed     Text format    


  292. ROKX C, Vella S, Pantaleo G, Levy Y, et al
    Unite forces to validate biomarkers in the quest for lasting HIV remission.
    AIDS. 2016;30:1859-60.
    PubMed     Text format    


  293. DES JARLAIS DC, Carrieri P
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.
    AIDS. 2016;30:1858-9.
    PubMed     Text format    


  294. CAZEIN F, Pillonel J, Barin F, Jauffret-Roustide M, et al
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.
    AIDS. 2016;30:1857-8.
    PubMed     Text format    


  295. BOYD A, Lacombe K, Girard PM
    An improved understanding of severe liver morbidity in HIV-infected individuals.
    AIDS. 2016;30:1843-5.
    PubMed     Text format    


  296. AHMAD A, Mehraj V, Jenabian MA, Samarani S, et al
    Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.
    AIDS. 2016;30:1839-41.
    PubMed     Text format    


  297. YEK C, Gianella S, Plana M, Castro P, et al
    Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  298. ARPADI SM, Shiau S, Strehlau R, Patel F, et al
    Efavirenz is associated with higher bone mass in South African children with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  299. PARK SY, Mack WJ, Lee HY
    Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  300. CHEW KW, Bhattacharya D
    Virologic and immunologic aspects of HIV-HCV coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  301. EVANS C, Chasekwa B, Ntozini R, Humphrey JH, et al
    Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the pre-ART era.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  302. VOSS JE, Macauley MS, Rogers KA, Villinger F, et al
    Reproducing SIVDeltanef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  303. SAMRI A, Bacchus-Souffan C, Hocqueloux L, Avettand-Fenoel V, et al
    Polyfunctional HIV-specific T-cells in post-treatment controllers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  304. DE MONTEYNARD LA, Matheron S, Gilquin J, Pavie J, et al
    Influence of geographic origin, sex and HIV transmission group on the outcome of first-line combined antiretroviral therapy (cART) in France.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    June 2016
  305. OLIVEIRA M, Ibanescu RI, Pham HT, Brenner B, et al
    The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  306. HONTELEZ JA, Chang AY, Ogbuoji O, Vlas SJ, et al
    Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  307. HARPER K
    The emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland.
    AIDS. 2016.
    PubMed     Text format    


  308. ROBERTSON KR, Miyahara S, Lee A, Brown TT, et al
    Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  309. DUARTE F, Miranda AC, Peres S, Diogo I, et al
    Transmitted drug resistance in drug-naive HIV-2 infected patients.
    AIDS. 2016;30:1687-8.
    PubMed     Text format    


  310. GERVASONI C, Minisci D, Meraviglia P, Baldelli S, et al
    Determinants of bone diseases in tenofovir-treated HIV patients.
    AIDS. 2016;30:1686-7.
    PubMed     Text format    


  311. HAGAN H, Jordan AE, Cleland CM
    Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply.
    AIDS. 2016;30:1685.
    PubMed     Text format    


  312. MOOG C, Mayr L, Tolstrup M
    New insights on the phenotype of HIV reservoirs.
    AIDS. 2016;30:1675-6.
    PubMed     Text format    


  313. MAKUMBI FE, Ssempijja V, Sekasanvu J, Ssekubugu R, et al
    Postcoital penile washing and the risk of HIV acquisition in uncircumcised men.
    AIDS. 2016;30:1669-73.
    PubMed     Text format     Abstract available


  314. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


  315. MOLDT B, Le KM, Carnathan DG, Whitney JB, et al
    Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.
    AIDS. 2016;30:1543-51.
    PubMed     Text format     Abstract available


  316. KOJIMA N, Davey DJ, Klausner JD
    Pre-exposure prophylaxis for human immunodeficiency virus and sexually transmitted infection acquisition among men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  317. LESKO CR, Edwards JK, Moore RD, Lau B, et al
    A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of injection drug use.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  318. FITCH KV, DeFilippi C, Christenson R, Srinivasa S, et al
    Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  319. DELVA W, Leventhal GE, Helleringer S
    Connecting the dots: network data and models in HIV epidemiology.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  320. AMU S, Fievez V, Nozza S, Lopalco L, et al
    Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 Infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  321. YONG YK, Shankar EM, Solomon A, Spelman T, et al
    Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  322. GARCIA M, Le Moal G, Godet C, Beraud G, et al
    First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
    AIDS. 2016;30:1487-8.
    PubMed     Text format    


  323. KADEDE K, Ruel T, Kabami J, Ssemmondo E, et al
    Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  324. MUMMERT C, Hofmann C, Huckelhoven AG, Bergmann S, et al
    T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  325. VAN DEN KERKHOF TL, van Gils MJ, Boeser-Nunnink BD, Burger JA, et al
    Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  326. FERGUSON D, Clarke S, Berry N, Almond N, et al
    Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    May 2016
  327. GIROMETTI N, Jones R, Levy J, McCormack S, et al
    Risks and benefits of HIV pre exposure prophylaxis with tenofovir/emtricitabine in an older man with co-morbidities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  328. JIN C, Peng X, Liu F, Cheng L, et al
    Interferon-induced SAMHD1 expression in astrocytes and microglia is mediated by miR-181a.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  329. KAGAAYI J, Kong X, Kigozi G, Ssekubugu R, et al
    Self-selection of male circumcision clients and behaviors following circumcision in a service program in rakai, Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  330. LONGENECKER CT, Sattar A, Gilkeson R, Mccomsey GA, et al
    Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  331. MONROE AK, Haberlen SA, Post WS, Palella FJ Jr, et al
    Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and-uninfected men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  332. AKGUN KM, Tate JP, Oursler KK, Crystal S, et al
    Association of chronic obstructive pulmonary disease (COPD) with frailty measurements in HIV-infected and uninfected Veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  333. NGUYEN TP, Shukla S, Asaad R, Freeman ML, et al
    Responsiveness to IL-7 but not to IFN-alpha is diminished in CD4 T cells from treated HIV infected patients who experience poor CD4 T cell recovery.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  334. ASAHCHOP EL, Akinwumi SM, Branton WG, Fujiwara E, et al
    Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  335. BREY FL, Seybold U, Kollan C, Bogner JR, et al
    Accelerated CD4 decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  336. KOZLOWSKI HN, Lai ET, Havugimana PC, White C, et al
    Extracellular histones identified in crocodile blood inhibit in vitro HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  337. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico: Erratum.
    AIDS. 2016;30:1325.
    PubMed     Text format    


  338. PENOT P, Gosset C, Verine J, Molina JM, et al
    Tenofovir disoproxil fumarate-induced Fanconi's syndrome during HIV postexposure prophylaxis.
    AIDS. 2016;30:1311-3.
    PubMed     Text format    


  339. KUMAR A, Dogra S, Gupta A, Suri D, et al
    Treatment of vitiligo with antiretroviral therapy in a child with HIV infection.
    AIDS. 2016;30:1309-10.
    PubMed     Text format    


  340. HATCHER AM, Bonell CP
    High time to unpack the 'how' and 'why' of adherence interventions.
    AIDS. 2016;30:1301-4.
    PubMed     Text format    


  341. WAMALWA D, Benki-Nugent S, Langat A, Tapia K, et al
    Treatment interruption after 2-year antiretroviral treatment (ART) initiated during acute/early HIV in infancy: a randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  342. OKULICZ JF, Boufassa F, Costagliola D, Ganesan A, et al
    Cancers In Elite Controllers: Appropriate Follow-up is Essential.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  343. VASE MO, Ludvigsen M, Bendix K, Hamilton-Dutoit S, et al
    Proteomic profiling of pre-treatment serum from HIV infected patients identifies candidate markers predictive of lymphoma development.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  344. HSU DC, Ma YF, Hur S, Li D, et al
    Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  345. CHEN P, Yi Z, Zhang W, Klotman ME, et al
    HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2 driven CD4+ T cell chemotactic response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  346. JASKIEWICZ W, Oketcho V, Settle D, Frymus D, et al
    Investing in the health workforce to increase access to and use of HIV and AIDS services in Uganda.
    AIDS. 2016.
    PubMed     Text format    


  347. ANGLEWICZ P, VanLandingham M, Manda-Taylor L, Kohler HP, et al
    Migration and HIV infection in malawi: A population-based longitudinal study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  348. JEAN K, Puren A, Cutler E, Singh B, et al
    Level of Viral Suppression and the Cascade of HIV Care in a South-African Semi-urban Setting in 2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  349. CROWELL TA, Phanuphak N, Pinyakorn S, Kroon E, et al
    Virologic failure is uncommon after treatment initiation during acute HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  350. BACHLE SM, Malone DF, Buggert M, Karlsson AC, et al
    Elevated levels of iNKT cell and NK cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  351. LAUT K, Shepherd LC, Pedersen C, Rockstroh JK, et al
    Associations between HIV-RNA-based indicators and virological and clinical outcomes.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  352. FONNER VA, Dalglish SL, Kennedy CE, Baggaley R, et al
    Effectiveness and safety of oral HIV pre-exposure prophylaxis (PrEP) for all populations: A systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  353. KHELOUFI F, Bellissant E, Cotte L, Poizot-Martin I, et al
    eGFR but not SLC polymorphisms influences anemia in HIV-HCV co-infected patients treated with boceprevir- or telaprevir-based therapy (ANRS HC26 and HC27 Study).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  354. PAZ-BAILEY G, Mendoza M, Finlayson T, Wejnert C, et al
    Trends in condom use among men who have sex with men in the united states: the role of antiretroviral therapy and sero-adaptive strategies.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  355. SU T, Wit FW, Caan MW, Schouten J, et al
    White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  356. STUEHLER C, Bernardini C, Elzi L, Stoeckle M, et al
    Immune recovery in HIV-infected patients after candida esophagitis is impaired despite long-term antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  357. HARPER K
    PrEP on demand dramatically reduces HIV incidence in men who have sex with men.
    AIDS. 2016.
    PubMed     Text format    


  358. TOBIN SC
    Protecting the mucosal immune response in treatment-naive HIV-infected patients.
    AIDS. 2016.
    PubMed     Text format    


  359. TOBIN SC
    Recent Advances in CRISPR/Cas9 Technology for Targeting Latent HIV-1 Reservoirs.
    AIDS. 2016.
    PubMed     Text format    


    April 2016
  360. EISEN S, Hayden C, Young CJ, Gilson R, et al
    B cell development and pneumococcal immunity in vertically-acquired HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  361. TAN WS, Chow EP, Fairley CK, Chen MY, et al
    Sensitivity of HIV rapid tests compared to fourth generation enzyme immunoassays or HIV RNA tests - a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  362. LEE GQ, Lachowski C, Cai E, Lima VD, et al
    Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pre-therapy CD4 count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  363. GHIGLIONE Y, Ruiz MJ, Salido J, Trifone C, et al
    Modification of the HIV-specific CD8+ T-cell response in an HIV Elite Controller after Chikungunya virus infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  364. POLITCH JA, Mayer KH, Anderson DJ
    HIV-1 is undetectable in pre-ejaculatory secretions from HIV-1-infected men on suppressive HAART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  365. HSIEH E, Fraenkel L, Han Y, Xia W, et al
    Longitudinal Increase in Vitamin D Binding Protein Levels after Initiation of Tenofovir/Lamivudine/Efavirenz among Individuals with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  366. MCCOY SI, Fahey C, Buzdugan R, Mushavi A, et al
    Targeting eMTCT efforts using geospatial analysis of mother-to-child HIV transmission in Zimbabwe.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  367. HUGHES RA
    Predicting virological decay in patients starting combination antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  368. GARCIA-ALVAREZ M, Berenguer J, Jimenez-Sousa MA, Vazquez-Moron S, et al
    Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.
    AIDS. 2016;30:1069-1074.
    PubMed     Text format     Abstract available


  369. MARTINS J, Santos E, Salgado P, Maia L, et al
    Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.
    AIDS. 2016;30:1143-4.
    PubMed     Text format    


  370. SANTULLI P, de Villardi D, Gayet V, Lafay Pillet MC, et al
    Decreased ovarian reserve in HIV-infected women.
    AIDS. 2016;30:1083-8.
    PubMed     Text format     Abstract available


  371. TINCATI C, Merlini E, Braidotti P, Ancona G, et al
    Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    AIDS. 2016;30:991-1003.
    PubMed     Text format     Abstract available


  372. FIORE JR, Zoboli F, Di Stefano M, Faleo G, et al
    Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
    AIDS. 2016;30:1144-6.
    PubMed     Text format    


  373. ALVAREZ-ROMAN MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, et al
    Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
    AIDS. 2016;30:1141-2.
    PubMed     Text format    


  374. DAVEY DJ, Vermund SH, Wamai R, Phili R, et al
    Why wait? We need to scale up infant male circumcision for global HIV control.
    AIDS. 2016.
    PubMed     Text format    


  375. LEE SA, Mefford JA, Huang Y, Witte JS, et al
    Host Genetic Predictors of the Kynurenine Pathway of Tryptophan Catabolism Among Treated HIV-Infected Ugandans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  376. KOOIJ KW, Wit FW, Van Zoest RA, Schouten J, et al
    Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  377. EATON EF, Tamhane A, Saag M, Mugavero MJ, et al
    Cost considerations in the current ARV era.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  378. HAYES PJ, Cox JH, Coleman AR, Fernandez N, et al
    Adenovirus based HIV-1 vaccine candidates tested in efficacy trials elicit CD8 T-cells with limited breadth of HIV-1 inhibition.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  379. MUSIIME V, Kasirye P, Naidoo-James B, Nahirya-Ntege P, et al
    Once versus twice daily abacavir and lamivudine in African children: The randomised controlled ARROW Trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  380. REDDY K, Ooms M, Letko M, Garrett N, et al
    Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  381. PARK LS, Tate JP, Sigel K, Rimland D, et al
    Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  382. BUZDUGAN R, Dufour MK, Mccoy SI, Watadzaushe C, et al
    Option A improved HIV-free infant survival and mother to child HIV transmission at 9-18 months in zimbabwe.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  383. CHUNG MH, Silverman R, Beck IA, Yatich N, et al
    Increasing HIV-1 pre-treatment drug resistance among antiretroviral-naive adults initiating treatment between 2006 and 2014 in Nairobi, Kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  384. CUNHA-SANTOS C, Figueira TN, Borrego P, Oliveira SS, et al
    Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  385. NOU E, Lo J, Grinspoon SK
    Inflammation, immune activation, and cardiovascular disease in HIV.
    AIDS. 2016.
    PubMed     Text format    


  386. TSO LS, Best J, Beanland R, Doherty M, et al
    Facilitators and barriers in HIV linkage to care interventions: a qualitative evidence review.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    March 2016
  387. MEHRAJ V, Jenabian MA, Ponte R, Lebouche B, et al
    The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  388. WRIGHT PW, Pyakurel A, Vaida FF, Price RW, et al
    Putamen volume and its clinical and neurological correlates in primary HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  389. LAMPE F
    Sexual behaviour among people with HIV according to self-reported antiretroviral and viral load status. Results from the ASTRA study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  390. CLIFTON S, Nardone A, Field N, Mercer CH, et al
    HIV testing, risk perception, and behaviour in the British population.
    AIDS. 2016;30:943-52.
    PubMed     Text format     Abstract available


  391. LEITMAN EM, Willberg CB, De Burgh-Thomas A, Streeck H, et al
    Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller.
    AIDS. 2016;30:972-4.
    PubMed     Text format    


  392. YANAGISAWA K, Nagano D, Ogawa Y, Uchiumi H, et al
    Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study.
    AIDS. 2016;30:970-2.
    PubMed     Text format    


  393. CAMLIN CS, Seeley J, Viljoen L, Vernooij E, et al
    Strengthening universal HIV 'test-and-treat' approaches with social science research.
    AIDS. 2016;30:969-70.
    PubMed     Text format    


  394. CASTILHO JL, Shepherd BE, Koethe J, Turner M, et al
    CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.
    AIDS. 2016;30:899-908.
    PubMed     Text format     Abstract available


  395. KAPOGIANNIS BG, Leister E, Siberry GK, Van Dyke RB, et al
    Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.
    AIDS. 2016;30:889-98.
    PubMed     Text format     Abstract available


  396. BRADBURY M, Cabrera S, Garcia-Jimenez A, Franco-Camps S, et al
    Vulvar intraepithelial neoplasia: clinical presentation, management and outcomes in women infected with HIV.
    AIDS. 2016;30:859-68.
    PubMed     Text format     Abstract available


  397. JEAN K, Niangoran S, Danel C, Moh R, et al
    Early ART initiation in west africa has no adverse social consequences: a 24-month prospective study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  398. MOLDT B, Le K, Carnathan DG, Whitney JB, et al
    Neutralizing antibody affords comparable protection against vaginal and rectal SHIV challenge in macaques.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  399. LI JF, Linley L, Kline R, Ziebell R, et al
    Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  400. MAKUMBI FE, Ssempijja V, Sekasanvu J, Ssekubugu R, et al
    Post-coital penile washing and the risk of HIV-acquisition in uncircumcised men, in Rakai, Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  401. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  402. YIN C, Zhang T, Li F, Yang F, et al
    Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  403. PALAR K, Laraia B, Tsai AC, Johnson M, et al
    Food insecurity is associated with HIV, sexually transmitted infections and drug use among men in the United States.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  404. KREBS SJ, Slike BM, Sithinamsuwan P, Allen IE, et al
    Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  405. GIANESIN K, Noguera-Julian A, Zanchetta M, Del Bianco P, et al
    Premature aging and immune senescence in HIV-infected children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  406. FITZPATRICK ME, Nouraie M, Gingo MR, Camp D, et al
    Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  407. LESKO CR, Moore RD, Tong W, Lau B, et al
    Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  408. MATEY EJ, Tokoro M, Nagamoto T, Mizuno T, et al
    Lower prevalence of Entamoeba species in children with vertically transmitted HIV infection in Western Kenya.
    AIDS. 2016;30:803-5.
    PubMed     Text format     Abstract available


  409. HARPER KN
    Understanding HIV/AIDS: six questions to consider.
    AIDS. 2016;30:N1.
    PubMed     Text format    


  410. NEWMAN CE, Persson A, Bains A, De Wit J, et al
    Whose voices inform online representations of HIV treatment as prevention?
    AIDS. 2016;30:808-10.
    PubMed     Text format    


  411. NAKANJAKO D, Kiragga AN, Musick B, Yiannoutsos C, et al
    Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy (ART) within the IeDEA-East Africa cohort.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  412. MBUGUA KK, Holmes MJ, Cotton MF, Ratai EM, et al
    HIV-associated CD4/8 depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  413. WANG L, Zhao J, Ren JP, Wu XY, et al
    Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  414. SCHNEIDER MT, Birger M, Haakendstad A, Singh L, et al
    Tracking development assistance for HIV/AIDS: The international response to a global epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  415. SUMNER T, Houben RM, Rangaka MX, Maartens G, et al
    Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  416. HATLEBERG CI, Ryom L, El-Sadr W, Smith C, et al
    Improvements over time in short-term mortality following myocardial infarction in the D: A: D Study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  417. YANIK EL, Katki HA, Engels EA
    Cancer Risk among the HIV-Infected Elderly in the United States.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  418. AUDSLEY J, Bent SJ, Littlejohn M, Avihingsanon A, et al
    Effects of long-term tenofovir-based cART in HIV-HBV co-infection on persistent HBV viremia and the role of HBV quasispecies diversity.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    February 2016
  419. NOBREGA C, Horta A, Coutinho-Teixeira V, Martins-Ribeiro A, et al
    Longitudinal evaluation of regulatory T cells dynamics on HIV-infected individuals during the first two years of therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  420. ANDERSON SJ
    Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planning.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  421. CHONG H, Wu X, Su Y, He Y, et al
    Development of potent and long-acting HIV-1 fusion inhibitors.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  422. SHIBOSKI CH, Lee A, Chen H, Webster-Cyriaque J, et al
    Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  423. NISHIJIMA T, Kurosawa T, Tanaka N, Kawasaki Y, et al
    Urinary beta2 microglobulin can predict TDF-related renal dysfunction in HIV-1-infected patients who initiate TDF-containing antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  424. CASADO JL, Santiuste C, Vazquez M, Banon S, et al
    Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  425. BURCH LS, Smith CJ, Phillips AN, Johnson MA, et al
    Socio-economic status and response to antiretroviral therapy in high-income countries: a literature review.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  426. GARCIA-OTERO L, Lopez M, Gomez O, Gonce A, et al
    Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  427. MAKINSON A, Eymard-Duvernay S, Raffi F, Abgrall S, et al
    Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.
    AIDS. 2016;30:573-82.
    PubMed     Text format     Abstract available


  428. CHOW D, Kohorn L, Souza S, Ndhlovu L, et al
    Atazanavir use and carotid intima media thickness progression in HIV: potential influence of bilirubin.
    AIDS. 2016;30:672-4.
    PubMed     Text format    


  429. GATES TM, Cysique LA, Siefried KJ, Chaganti J, et al
    Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.
    AIDS. 2016;30:591-600.
    PubMed     Text format     Abstract available


  430. KELLEY CF, Lai L, Ibegbu C, Rosenberg ES, et al
    Differences in expression of gut-homing receptors on CD4+T cells in black and white HIV-negative men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  431. GUTIERREZ C, Serrano-Villar S, Madrid-Elena N, Perez-Elias MJ, et al
    Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy: a phase i, double-blind clinical trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  432. FLANDRE P, Pugliese P, Allavena C, Bagnis CI, et al
    Does first line anti-retroviral regimen impact risk for chronic kidney disease whatever the risk-group?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  433. SCHNEIDER S, Spinner CD, Cassese S, Promny D, et al
    Association of increased CD8 and persisting CRP levels with restenosis in HIV patients after coronary stenting: the ISAR HIV study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  434. CANIGLIA EC, Patel K, Huo Y, Williams PL, et al
    Atazanavir exposure in utero and neurodevelopment in infants: A comparative safety study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  435. ROSSI C, Cox J, Cooper C, Martel-Laferriere V, et al
    Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV co-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  436. HARPER K
    Simplified HIV testing and treatment reduces mortality rate by over 60% in a trial in China.
    AIDS. 2016.
    PubMed     Text format    


  437. BOETTIGER DC, Sabin CA, Grulich A, Ryom L, et al
    Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  438. RAMIREZ CM, Sinclair E, Epling L, Lee SA, et al
    Immunologic profiles distinguish aviremic HIV-infected adults.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  439. STELLBRINK HJ, Fevre EL, Carr A, Saag MS, et al
    Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment: 48-week results from the MODERN study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  440. HLEYHEL M, Goujon S, Delteil C, Vasiljevic A, et al
    Risk of cancer in children exposed to didanosine in utero.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  441. HERRERA C, Armanasco N, Garcia-Perez J, Ziprin P, et al
    Maraviroc and reverse transcriptase inhibitors combinations as potential pre-exposure prophylaxis candidates.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  442. LEON A, Perez I, Ruiz-Mateos E, Benito JM, et al
    Rate and predictors of progression in elite and viremic HIV-1 controllers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  443. CAMUS C, Matusali G, Bourry O, Mahe D, et al
    Comparison of the effect of semen from HIV-infected and uninfected men on CD4+ T cell infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  444. MKHIZE NN, Durgiah R, Ashley V, Archary D, et al
    Broadly neutralizing antibody specificties detected in the genital tract of HIV-1 infected women.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  445. SCHALKWIJK S, Colbers A, Konopnicki D, Weizsacker K, et al
    The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant women.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  446. SCHOFIELD AM, Sadler L, Nelson L, Gittins M, et al
    A prospective study of anal cancer screening in HIV positive and negative men who have sex with men; results of Analogy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  447. DES JARLAIS DC, Kerr T, Carrieri P, Feelemyer J, et al
    HIV infection among persons who inject drugs: Ending old epidemics and addressing new outbreaks.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  448. ZACHOR H, Machekano R, Estrella MM, Veldkamp PJ, et al
    Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens: A cohort study in HIV-infected adults in Cape Town, South Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  449. CHILDS K, Taylor C, Dieterich D, Agarwal K, et al
    Directly acting antivirals (DAAs) for HCV arrive in HIV/HCV co-infected patients: from 'mind the gap' to 'where's the gap?'
    AIDS. 2016.
    PubMed     Text format    


    January 2016
  450. FORD N, Boulle A, Egger M
    Accounting for and responding to HIV-associated mortality.
    AIDS. 2016;30:521-523.
    PubMed     Text format    


  451. CAMLIN CS, Neilands TB, Odeny TA, Lyamuya R, et al
    Patient-reported factors associated with reengagement among HIV-infected patients disengaged from care in East Africa.
    AIDS. 2016;30:495-502.
    PubMed     Text format     Abstract available


  452. ASIKI G, Reniers G, Newton R, Baisley K, et al
    Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991-2012).
    AIDS. 2016;30:487-493.
    PubMed     Text format     Abstract available


  453. DEPP TB, McGinnis KA, Kraemer K, Akgun KM, et al
    Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.
    AIDS. 2016;30:455-463.
    PubMed     Text format     Abstract available


  454. ROLAND ME, Barin B, Huprikar S, Murphy B, et al
    Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.
    AIDS. 2016;30:435-444.
    PubMed     Text format     Abstract available


  455. KONOPNICKI D, Manigart Y, Gilles C, Barlow P, et al
    High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
    AIDS. 2016;30:425-433.
    PubMed     Text format     Abstract available


  456. GUTIERREZ J, Menshawy K, Gonzalez M, Goldman J, et al
    Brain large artery inflammation associated with HIV and large artery remodeling.
    AIDS. 2016;30:415-423.
    PubMed     Text format     Abstract available


  457. MARAIS S, Meintjes G, Lesosky M, Wilkinson KA, et al
    Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    AIDS. 2016;30:395-404.
    PubMed     Text format     Abstract available


  458. BARIGOU M, Garnier C, Debard A, Mengelle C, et al
    Favorable outcome of severe human herpes virus-6 encephalitis in an HIV-infected patient.
    AIDS. 2016;30:532-4.
    PubMed     Text format    


  459. BEGUELIN C, Vazquez M, Moradpour D, Sahli R, et al
    Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient.
    AIDS. 2016;30:530-3.
    PubMed     Text format    


  460. LE DOARE K, Taylor S, Allen L, Gorringe A, et al
    Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants.
    AIDS. 2016;30:471-5.
    PubMed     Text format     Abstract available


  461. JIMENEZ-SOUSA MA, Berenguer J, Garcia-Alvarez M, Gutierrez-Rivas M, et al
    Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.
    AIDS. 2016;30:465-70.
    PubMed     Text format     Abstract available


  462. ERLANDSON KM, Li X, Abraham AG, Margolick JB, et al
    Long-term impact of HIV wasting on physical function.
    AIDS. 2016;30:445-54.
    PubMed     Text format     Abstract available


  463. OFOTOKUN I, Titanji K, Vunnava A, Roser-Page S, et al
    Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection.
    AIDS. 2016;30:405-14.
    PubMed     Text format     Abstract available


  464. CHEVIGNE A, Delhalle S, Counson M, Beaupain N, et al
    Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller.
    AIDS. 2016;30:377-82.
    PubMed     Text format     Abstract available


  465. MAMMONE A, Pezzotti P, Regine V, Camoni L, et al
    How many people are living with undiagnosed HIV infection? an estimate for Italy, based on surveillance data.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  466. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  467. KHOURY G, Anderson JL, Fromentin R, Hartogensis W, et al
    Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T-cells in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  468. PICARD A, Badoual C, Hourseau M, Halimi C, et al
    HPV prevalence in HIV patients with head and neck squamous cell carcinoma.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  469. FONJUNGO PN, Osmanov S, Kuritsky J, Ndihokubwayo JB, et al
    Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  470. CASADELLA M, Noguera-Julian M, Sunpath H, Gordon M, et al
    Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  471. WARE NC, Pisarski EE, Tam M, Wyatt MA, et al
    The meanings in the messages: How SMS reminders and real-time adherence monitoring improve ART adherence in rural uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  472. MCCARTHY SD, Sakac D, Neschadim A, Branch DR, et al
    c-SRC protein tyrosine kinase regulates early hiv-1 infection post entry.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  473. VAR SR, Day TR, Vitomirov A, Smith DM, et al
    Mitochondrial injury and cognitive function in HIV infection and methamphetamine use.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  474. CORSI F, Fiandra L, Rizzardini G
    New perspectives on nanotechnology and antiretroviral drugs: a small solution for a big promise in HIV treatment?
    AIDS. 2016.
    PubMed     Text format    


  475. SANTULLI P, de Villardi D, Gayet V, Pillet ML, et al
    Decreased ovarian reserve in human immunodeficiency virus infected women: A matched cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  476. MUSINGUZI N, Muganzi CD, Boum Y 2nd, Ronald A, et al
    Comparison of subjective and objective adherence measures for pre-exposure prophylaxis against HIV infection among serodiscordant couples in East Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  477. KIM J, Scherzer R, Estrella M, Ix J, et al
    Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected Veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  478. GARDNER LI, Marks G, Shahani L, Giordano TP, et al
    Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  479. MANDORFER M, Schwabl P, Steiner S, Scheiner B, et al
    Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/HCV-coinfected patients with advanced liver disease.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  480. HABERER JE, Musiimenta A, Atukunda EC, Musinguzi N, et al
    SMS reminders plus real-time adherence monitoring improve adherence to antiretroviral therapy in rural Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  481. RYOM L, Lundgren JD, De Wit S, Kovari H, et al
    Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  482. RAYMOND S, Nicot F, Carcenac R, Jeanne N, et al
    No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients on suppressive maraviroc therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  483. TINCATI C, Merlini E, Braidotti P, Ancona G, et al
    Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically-suppressive cART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  484. KARO B, Krause G, Hollo V, van der Werf MJ, et al
    The impact of HIV infection on treatment outcome of tuberculosis: analysis of surveillance data from nine European countries, 2010-2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  485. SCHOUTEN J, Su T, Wit FW, Kootstra NA, et al
    Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  486. AGUILERA-SANDOVAL CR, Yang OO, Jojic N, Lovato P, et al
    Supranormal thymic output up to two decades after HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  487. ANANWORANICH J, Melvin D, Amador JT, Childs T, et al
    Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  488. CALIN R, Hamimi C, Lambert-Niclot S, Carcelain G, et al
    Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  489. BOON SD, Matteelli A, Ford N, Getahun H, et al
    Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  490. OLSZEWSKI AJ, Castillo JJ
    Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy: analysis of the National Cancer Data Base.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  491. FLEMING PJ, Dworkin SL
    The importance of masculinity and gender norms for understanding institutional responses to HIV testing and treatment strategies.
    AIDS. 2016;30:157-8.
    PubMed     Text format    


  492. OSTER AM
    The evolving contribution of emergency department testing studies: from risk to care.
    AIDS. 2016;30:151-2.
    PubMed     Text format    


  493. WILLIAMS PL, Hazra R, Van Dyke RB, Yildirim C, et al
    Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    AIDS. 2016;30:133-44.
    PubMed     Text format     Abstract available


  494. KELEN GD, Hsieh YH, Rothman RE, Patel EU, et al
    Improvements in the continuum of HIV care in an inner-city emergency department.
    AIDS. 2016;30:113-20.
    PubMed     Text format     Abstract available


  495. GRANT JL, Hawkins C, Brooks H, Palella FJ Jr, et al
    Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    AIDS. 2016;30:93-8.
    PubMed     Text format     Abstract available


  496. SENDAGORTA E, Bernardino JI, Alvarez-Gallego M, Feito M, et al
    Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
    AIDS. 2016;30:75-82.
    PubMed     Text format     Abstract available


  497. HILEMAN CO, Turner R, T Funderburg N, Semba RD, et al
    Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.
    AIDS. 2016;30:65-73.
    PubMed     Text format     Abstract available


  498. WEIS JF, Baeten JM, McCoy CO, Warth C, et al
    Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
    AIDS. 2016;30:31-5.
    PubMed     Text format     Abstract available


  499. YANG L, Poles MA, Fisch GS, Ma Y, et al
    HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria.
    AIDS. 2016;30:19-29.
    PubMed     Text format     Abstract available


  500. SPITS HB, Mudrikova T, Schellens IM, Wensing AM, et al
    The presence of protective cytotoxic T lymphocytes does not correlate with shorter lifespans of productively infected cells in HIV-1 infection.
    AIDS. 2016;30:9-17.
    PubMed     Text format     Abstract available


  501. NGOUPO PA, Sadeuh-Mba SA, De Oliveira F, Ngono V, et al
    First evidence of transmission of an HIV-1 M/O intergroup recombinant virus.
    AIDS. 2016;30:1-8.
    PubMed     Text format     Abstract available


  502. JANI IV, Quevedo JI, Tobaiwa O, Bollinger T, et al
    Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting.
    AIDS. 2016;30:159-61.
    PubMed     Text format    


  503. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    PubMed     Text format     Abstract available


  504. OLSTHOORN AV, Sivachandran N, Bogoch I, Kwantampora J, et al
    Barriers to the uptake of postexposure prophylaxis among Nairobi-based female sex workers.
    AIDS. 2016;30:99-103.
    PubMed     Text format     Abstract available


  505. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    PubMed     Text format     Abstract available


  506. SCHURMANN D, Sobotha C, Gilmartin J, Robberechts M, et al
    A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
    AIDS. 2016;30:57-63.
    PubMed     Text format     Abstract available


  507. SAVAGE EJ, Lowndes CM, Sullivan AK, Back DJ, et al
    Effect of nondisclosure of HIV status in sexual health clinics on unlinked anonymous HIV prevalence estimates in England, 2005-2009.
    AIDS. 2016;30:145-9.
    PubMed     Text format     Abstract available


  508. CHOW FC, Boscardin WJ, Mills C, Ko N, et al
    Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
    AIDS. 2016;30:45-55.
    PubMed     Text format     Abstract available


  509. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    PubMed     Text format     Abstract available


  510. BONACCI RA, Holtgrave DR
    Simplified estimates of HIV incidence and transmission rates for the USA, 2008-2012.
    AIDS. 2016;30:332-3.
    PubMed     Text format    


  511. SU T, Caan MW, Wit FW, Schouten J, et al
    White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment.
    AIDS. 2016;30:311-22.
    PubMed     Text format     Abstract available


  512. ENGELHARD EA, Smit C, Van Sighem A, Reiss P, et al
    Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands.
    AIDS. 2016;30:301-10.
    PubMed     Text format     Abstract available


  513. COLCHERO MA, Bautista-Arredondo S, Cortes-Ortiz MA, Romero-Martinez M, et al
    Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico.
    AIDS. 2016;30:293-300.
    PubMed     Text format     Abstract available


  514. PARK LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, et al
    Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.
    AIDS. 2016;30:273-91.
    PubMed     Text format     Abstract available


  515. TOWNSEND K, Petersen T, Gordon LA, Kohli A, et al
    Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir.
    AIDS. 2016;30:261-6.
    PubMed     Text format     Abstract available


  516. CROMER D, Grimm AJ, Schlub TE, Mak J, et al
    Estimating the in-vivo HIV template switching and recombination rate.
    AIDS. 2016;30:185-92.
    PubMed     Text format     Abstract available


  517. BALL C, Sudhanva M, Jarosz J, Post FA, et al
    Is there a role for maraviroc to treat HIV-associated central nervous system white matter disease?
    AIDS. 2016;30:334-6.
    PubMed     Text format    


  518. FAGIUOLI S, Puoti M, Rizzardini G
    Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?
    AIDS. 2016;30:323-5.
    PubMed     Text format    


  519. LEWIS JM, Volny-Anne A, Waitt C, Boffito M, et al
    Dosing antiretroviral medication when crossing time zones: a review.
    AIDS. 2016;30:267-71.
    PubMed     Text format     Abstract available


  520. VAN LUNZEN J, Antinori A, Cohen CJ, Arribas JR, et al
    Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.
    AIDS. 2016;30:251-9.
    PubMed     Text format     Abstract available


  521. KOOIJ KW, Wit FW, Schouten J, van der Valk M, et al
    HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls.
    AIDS. 2016;30:241-50.
    PubMed     Text format     Abstract available


  522. CASADO JL, Banon S, Santiuste C, Serna J, et al
    Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    AIDS. 2016;30:231-9.
    PubMed     Text format     Abstract available


  523. KATLAMA C, Lambert-Niclot S, Assoumou L, Papagno L, et al
    Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.
    AIDS. 2016;30:221-30.
    PubMed     Text format     Abstract available


  524. POWIS KM, Smeaton L, Hughes MD, Tumbare EA, et al
    In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.
    AIDS. 2016;30:211-20.
    PubMed     Text format     Abstract available


  525. EVERING TH, Applebaum A, La Mar M, Garmon D, et al
    Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
    AIDS. 2016;30:203-10.
    PubMed     Text format     Abstract available


    December 2015
  526. TWEYA H, Keiser O, Haas AD, Tenthani L, et al
    Comparative cost-effectiveness of Option B+ for prevention of mother to child transmission of HIV in Malawi: Mathematical modelling study.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  527. HARPER K
    The effects of the Affordable Care Act on low-income patients with HIV.
    AIDS. 2015.
    PubMed     Text format    


  528. HARPER K
    WHO releases a "treat-all" recommendation for HIV patients.
    AIDS. 2015.
    PubMed     Text format    


  529. HARPER K
    Protease inhibitor monotherapy for long-term management of HIV infection.
    AIDS. 2015.
    PubMed     Text format    


  530. HARPER K
    Romidepsin reverses HIV-1 latency in vivo.
    AIDS. 2015.
    PubMed     Text format    


  531. LIU L, Nardo D, Li E
    CD4+ T-cell recovery with suppressive ART induced rapid sequence evolution in HCV envelope but not NS3.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  532. ELAHI S, Weiss RH, Merani S
    Atorvastatin Restricts HIV Replication in CD4+ T Cells by Upregulation of p21.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  533. FARAHANI M, Price N, El-Halabi S, Mlaudzi N, et al
    Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  534. DE VOEGHT A, Maes N, Moutschen M
    sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  535. THOMPSON M, Saag M, Dejesus E, Gathe J, et al
    A 48-week randomized Phase 2b study evaluating cenicriviroc vs. efavirenz in treatment-naive HIV-infected adults with CCR5-tropic virus.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  536. CALCAGNO A, Cusato J, Marinaro L, Simiele M, et al
    Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  537. JOSEPH B, Wood E, Hayashi K, Kerr T, et al
    Factors associated with initiation of antiretroviral therapy among hiv-positive people who use injection drugs in a Canadian setting.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  538. SIEDNER MJ, Kim JH, Nakku RS, Hemphill L, et al
    HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  539. PANTAZIS N, Touloumi G, Meyer L, Olson A, et al
    The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  540. MARSHALL BD, Elston B, Dobrer S, Parashar S, et al
    The population Impact of eliminating homelessness on HIV viral suppression among people who use drugs.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  541. FERNANDEZ-SANCHEZ M, Iglesias MC, Ablanedo-Terrazas Y, Ormsby CE, et al
    Steroids are a risk factor for Kaposi sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  542. HARPER GW, Wade RM, Onyango DP, Abuor PA, et al
    Resilience among gay/bisexual young men in Western Kenya: psychosocial and sexual health outcomes.
    AIDS. 2015;29 Suppl 3:S261-S269.
    PubMed     Text format     Abstract available


  543. SECOR AM, Wahome E, Micheni M, Rao D, et al
    Depression, substance abuse and stigma among men who have sex with men in coastal Kenya.
    AIDS. 2015;29 Suppl 3:S251-S259.
    PubMed     Text format     Abstract available


  544. GRAHAM SM, Micheni M, Kombo B, Van Der Elst EM, et al
    Development and pilot testing of an intervention to promote care engagement and adherence among HIV-positive Kenyan MSM.
    AIDS. 2015;29 Suppl 3:S241-S249.
    PubMed     Text format     Abstract available


  545. MICHENI M, Rogers S, Wahome E, Darwinkel M, et al
    Risk of sexual, physical and verbal assaults on men who have sex with men and female sex workers in coastal Kenya.
    AIDS. 2015;29 Suppl 3:S231-S236.
    PubMed     Text format     Abstract available


  546. SANDERS EJ, Wahome E, Powers KA, Werner L, et al
    Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa.
    AIDS. 2015;29 Suppl 3:S221-S230.
    PubMed     Text format     Abstract available


  547. MOLLER LM, Stolte IG, Geskus RB, Okuku HS, et al
    Changes in sexual risk behavior among MSM participating in a research cohort in coastal Kenya.
    AIDS. 2015;29 Suppl 3:S211-S219.
    PubMed     Text format     Abstract available


  548. SMITH AD, Muhaari AD, Agwanda C, Kowuor D, et al
    Heterosexual behaviours among men who sell sex to men in coastal Kenya.
    AIDS. 2015;29 Suppl 3:S201-10.
    PubMed     Text format     Abstract available


    November 2015
  549. DOWNS JA, Msango L, Kalluvya SE, Kidenya BR, et al
    Renal dysfunction and schistosomiasis among HIV-infected patients starting antiretroviral therapy in Mwanza, Tanzania.
    AIDS. 2015;29:2532-3.
    PubMed     Text format    


  550. KONOU AA, Dagnra AY, Vidal N, Salou M, et al
    Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.
    AIDS. 2015;29:2527-30.
    PubMed     Text format     Abstract available


  551. HILL A, Pozniak A
    HIV treatment cascades: how can all countries reach the UNAIDS 90-90-90 target?
    AIDS. 2015;29:2523-5.
    PubMed     Text format    


  552. WHITESIDE YO, Song R, Wertheim JO, Oster AM, et al
    Molecular analysis allows inference into HIV transmission among young men who have sex with men in the United States.
    AIDS. 2015;29:2517-22.
    PubMed     Text format     Abstract available


  553. RICHARDSON LA, Kerr TH, Dobrer S, Puskas CM, et al
    Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
    AIDS. 2015;29:2487-95.
    PubMed     Text format     Abstract available


  554. LEWIS JM, Macpherson P, Adams ER, Ochodo E, et al
    Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1: a systematic review.
    AIDS. 2015;29:2465-71.
    PubMed     Text format     Abstract available



  555. Once vs. twice-daily lopinavir/ritonavir in HIV-1-infected children.
    AIDS. 2015;29:2447-57.
    PubMed     Text format     Abstract available


  556. CORI A, Pickles M, van Sighem A, Gras L, et al
    CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.
    AIDS. 2015;29:2435-46.
    PubMed     Text format     Abstract available


  557. KINGSLEY LA, Deal J, Jacobson L, Budoff M, et al
    Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men.
    AIDS. 2015;29:2427-34.
    PubMed     Text format     Abstract available


  558. ANDRADE A, Guedj J, Rosenkranz SL, Lu D, et al
    Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).
    AIDS. 2015;29:2419-26.
    PubMed     Text format     Abstract available


  559. KELLER MJ, Mesquita PM, Marzinke MA, Teller R, et al
    A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  560. HOFFMANN C, Schommers P, Wolf E, Muller M, et al
    CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing hodgkin or non hodgkin lymphoma.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  561. TALBERT-SLAGLE KM, Canavan ME, Rogan EM, Curry LC, et al
    State variation in HIV/AIDS health outcomes: the effect of spending on social services and public health.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  562. AHAMED J, Terry H, Choi ME, Laurence J, et al
    Transforming Growth Factor-beta1-mediated cardiac fibrosis: Potential role in HIV and HIV/ART-linked cardiovascular disease.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  563. MAFFONGELLI G, Alterib C, Gentilotti E, Bertoli A, et al
    Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  564. PETERS MG, Bacchetti P, Boylan R, French AL, et al
    Enhanced liver fibrosis marker as a non-invasive predictor of mortality in HIV/HCV-coinfected women from the women's Interagency HIV study.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  565. LETH S, Nymann R, JOrgensen S, Olesen R, et al
    HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on ART.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  566. MCFARREN A, Lopez L, Williams DW, Veenstra M, et al
    A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  567. VAN TRAN G, Chikata T, Carlson JM, Murakoshi H, et al
    A strong association of HLA-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  568. LI W, Yu F, Wang Q, Qi Q, et al
    Co-delivery of HIV-1 entry inhibitor and NNRTI shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  569. TSITSI B, Grace M, Ethel D, Stanley M, et al
    Validation of a screening tool to identify older children living with HIV in primary care facilities in high HIV prevalence settings.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  570. LI JZ, Etemad B, Ahmed H, Aga E, et al
    The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  571. HOOD JE, Buskin SE, Dombrowski JC, Kern DA, et al
    Dramatic increase in preexposure prophylaxis use among MSM in King County, Washington.
    AIDS. 2015.
    PubMed     Text format     Abstract available



  572. Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  573. HULLEGIE SJ, de Winter BC, Posthouwer D, Koopmans PP, et al
    Safety of rilpivirine and boceprevir co-administration in HIV-infected patients treated for acute hepatitis C virus infection.
    AIDS. 2015.
    PubMed     Text format    


  574. WAKE R, Glencross DK, Sriruttan C, Harrison TS, et al
    Cryptococcal antigen screening in HIV-infected adults - let's get straight to the point-of-care.
    AIDS. 2015.
    PubMed     Text format    


  575. LUCAS GM, Atta MG, Zook K, McFall AM, et al
    Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  576. NOU E, Lu MT, Looby SE, Fitch KV, et al
    Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  577. VANPOUILLE C, Introini A, Morris SR, Margolis L, et al
    Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  578. KASIRYE RP, Baisley K, Munderi P, Levin J, et al
    Incidence of malaria by cotrimoxazole use in HIV infected Ugandan adults on antiretroviral therapy: a randomized placebo controlled study.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  579. GOESER F, Glassner A, Kokordelis P, Wolter F, et al
    HIV mono-infection is associated with an impaired anti-HCV activity of NK cells.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  580. EADES CP, Herbert SA, Edwards SG, Waters LJ, et al
    High rate of lymphoma among a UK cohort of adolescents with vertically acquired HIV-1 infection transitioning to adult care in the era of antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  581. BEDIMO R, Cutrell J, Zhang S, Drechsler H, et al
    Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  582. KERR T, Shannon K, Ti L, Strathdee S, et al
    Sex work and HIV incidence among people who inject drugs.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  583. RALLON NI, Mothe B, Lopez Bernaldo DE Quiros JC, Plana M, et al
    Balance between activation and regulation of HIV-specific CD8 T cells response after MVA-B therapeutic vaccination.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  584. BAXI SM, Scherzer R, Greenblatt RM, Minkoff H, et al
    Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  585. LOU AD, Pannetier J, Ravalihasy A, Le Guen M, et al
    Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-saharan African Migrants in France.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  586. BORHIS G, Burelout C, Chaoul N, Smith N, et al
    Plasmacytoid dendritic cells and myeloid cells differently contribute to BAFF over-expression during primary HIV infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  587. VIVITHANAPORN P, Asahchop EL, Acharjee S, Baker GB, et al
    HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  588. SIRERA G, Videla S, Verges J, Chamorro A, et al
    Aggressive human papillomavirus (HPV)-11-related sinonasal inverted papilloma in an HIV-infected patient and the quadrivalent HPV vaccine: a case report.
    AIDS. 2015;29:2366-8.
    PubMed     Text format    


  589. SHEARER GM, Clerici M, Graham DR, Boasso A, et al
    Curing HIV/AIDS beyond hematopoietic stem cell transplant.
    AIDS. 2015;29:2364-6.
    PubMed     Text format    


  590. MEIJIDE H, Mena A, Marcos PJ, Rodriguez-Osorio I, et al
    Lung cancer in patients living with HIV infection.
    AIDS. 2015;29:2363-4.
    PubMed     Text format    


  591. PYRA M, Heffron R, Mugo NR, Nanda K, et al
    Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
    AIDS. 2015;29:2353-9.
    PubMed     Text format     Abstract available


  592. LOUBET P, Mabileau G, Baysah M, Nuta C, et al
    Likely effect of the 2014 Ebola epidemic on HIV care in Liberia.
    AIDS. 2015;29:2347-51.
    PubMed     Text format     Abstract available


  593. JARRIN I, Pantazis N, Dalmau J, Phillips AN, et al
    Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
    AIDS. 2015;29:2323-33.
    PubMed     Text format     Abstract available


  594. AHLSTROM MG, Kronborg G, Larsen CS, Pedersen C, et al
    Incidence of benign prostate hypertrophy in Danish men with and without HIV infection.
    AIDS. 2015;29:2315-22.
    PubMed     Text format     Abstract available


  595. TREVILLYAN JM, Arthur JF, Jing J, Andrews RK, et al
    Effects of abacavir administration on structural and functional markers of platelet activation.
    AIDS. 2015;29:2309-13.
    PubMed     Text format     Abstract available


  596. MORSE CG, McLaughlin M, Proschan M, Koh C, et al
    Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy.
    AIDS. 2015;29:2297-302.
    PubMed     Text format     Abstract available


  597. HUNTINGTON S, Thorne C, Newell ML, Anderson J, et al
    The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy.
    AIDS. 2015;29:2269-78.
    PubMed     Text format     Abstract available


  598. BACHMANN MO, Timmerman V, Fairall LR
    Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
    AIDS. 2015;29:2261-8.
    PubMed     Text format     Abstract available


  599. BANSAL A, Sterrett S, Erdmann N, Westfall AO, et al
    Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts.
    AIDS. 2015;29:2245-54.
    PubMed     Text format     Abstract available


    October 2015
  600. LOOBY SE, Fitch KV, Srinivasa S, Lo J, et al
    Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  601. HARPER KN
    The best way to proceed when an HIV-discordant couple desires a child.
    AIDS. 2015;29:N23.
    PubMed     Text format    


  602. HARPER KN
    Replicative fitness of transmitted HIV-1 drives disease progression.
    AIDS. 2015;29:N21.
    PubMed     Text format    


  603. HARPER KN
    Organ donations between HIV-positive individuals.
    AIDS. 2015;29:N19.
    PubMed     Text format    


  604. HARPER KN
    Effective but expensive hepatitis C treatment for patients with HIV.
    AIDS. 2015;29:N17.
    PubMed     Text format    


  605. LIN KY, Hung CC
    Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
    AIDS. 2015;29:2213-4.
    PubMed     Text format    


  606. VISSEAUX B, Charpentier C, Ozanne A, Nizard A, et al
    Tropism distribution among antiretroviral-naive HIV-2-infected patients.
    AIDS. 2015;29:2209-12.
    PubMed     Text format     Abstract available


  607. CONLEY LJ, Bush TJ, Rupert AW, Sereti I, et al
    Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy.
    AIDS. 2015;29:2201-7.
    PubMed     Text format     Abstract available


  608. GLASS TR, Sterne JA, Schneider MP, De Geest S, et al
    Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
    AIDS. 2015;29:2195-200.
    PubMed     Text format     Abstract available


  609. VAN DER STRATEN A, Montgomery ET, Musara P, Etima J, et al
    Disclosure of pharmacokinetic drug results to understand nonadherence.
    AIDS. 2015;29:2161-71.
    PubMed     Text format     Abstract available


  610. PALLADINO C, Gomez ML, Soler-Palacin P, Gonzalez-Tome MI, et al
    Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice.
    AIDS. 2015;29:2155-9.
    PubMed     Text format     Abstract available


  611. COLL J, Molto J, Boix J, Gomez-Mora E, et al
    Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
    AIDS. 2015;29:2149-54.
    PubMed     Text format     Abstract available


  612. JANSSEN MA, Meulenbroek O, Steens SC, Goraj B, et al
    Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
    AIDS. 2015;29:2139-48.
    PubMed     Text format     Abstract available


  613. CILLO AR, Hilldorfer BB, Lalama CM, McKinnon JE, et al
    Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    AIDS. 2015;29:2121-9.
    PubMed     Text format     Abstract available


  614. DUFFAU P, Wittkop L, Lazaro E, le Marec F, et al
    Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients.
    AIDS. 2015;29:2099-108.
    PubMed     Text format     Abstract available


  615. GIANELLA S, Anderson CM, Richman DD, Smith DM, et al
    No evidence of posttreatment control after early initiation of antiretroviral therapy.
    AIDS. 2015;29:2093-7.
    PubMed     Text format     Abstract available


  616. COHN J, Bekker LG, Bygrave H, Calmy A, et al
    Hit me with your best shot: dolutegravir - a space in the next WHO guidelines?
    AIDS. 2015;29:2067-70.
    PubMed     Text format    


    September 2015
  617. KOETHE JR, Grome H, Jenkins CA, Kalams SA, et al
    The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: